- Home
- SID vs OCUL Comparison
SID vs OCUL Comparison
Compare SID & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SID | OCUL |
|---|---|---|
| Founded | 1941 | 2006 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SID | OCUL |
|---|---|---|
| Price | $1.28 | $8.26 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $1.40 | ★ $23.56 |
| AVG Volume (30 Days) | ★ 7.6M | 4.1M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $2.38 | $7.93 |
| Revenue Next Year | $2.49 | $94.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $1.11 | $6.23 |
| 52 Week High | $2.20 | $16.44 |
Technical Indicators
Market Signals| Indicator | SID | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 45.38 |
| Support Level | N/A | $6.23 |
| Resistance Level | $1.64 | $12.38 |
| Average True Range (ATR) | 0.06 | 0.44 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 84.21 | 54.52 |
Price Performance
Historical ComparisonAbout SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.